openPR Logo
Press release

microRNA Market worth $12.51 billion by 2030, growing at a CAGR of 28.77% - Exclusive Report by 360iResearch

10-04-2023 09:32 AM CET | Health & Medicine

Press release from: 360iResearch

microRNA Market | 360iResearch

microRNA Market | 360iResearch

The "microRNA Market by Assay Type (Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays), Product (Consumables, Instruments), Services Type, Application - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/microrna?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Market Segmentation & Coverage:

This research report categorizes the microRNA Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Assay Type, market is studied across Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays, Immunoassay, miRNA Arrays, Next-Generation Sequencing, and PCR-Based Assay. The Colorimetric Assays is projected to witness significant market share during forecast period.

Based on Product, market is studied across Consumables and Instruments. The Consumables is projected to witness significant market share during forecast period.

Based on Services Type, market is studied across Functional Studies Services and Microarray Services. The Functional Studies Services is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cancer, Cardiovascular Disease, Immunological Disorder, Infectious Diseases, and Neurological Diseases. The Neurological Diseases is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the microRNA Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the microRNA Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the microRNA Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. microRNA Market, by Assay Type
7. microRNA Market, by Product
8. microRNA Market, by Services Type
9. microRNA Market, by Application
10. Americas microRNA Market
11. Asia-Pacific microRNA Market
12. Europe, Middle East & Africa microRNA Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the microRNA Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the microRNA Market?
3. What is the competitive strategic window for opportunities in the microRNA Market?
4. What are the technology trends and regulatory frameworks in the microRNA Market?
5. What is the market share of the leading vendors in the microRNA Market?
6. What modes and strategic moves are considered suitable for entering the microRNA Market?

Read More @ https://www.360iresearch.com/library/intelligence/microrna?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release microRNA Market worth $12.51 billion by 2030, growing at a CAGR of 28.77% - Exclusive Report by 360iResearch here

News-ID: 3234167 • Views:

More Releases from 360iResearch

Embedded Finance Market worth $228.79 billion by 2030, growing at a CAGR of 18.75% - Exclusive Report by 360iResearch
Embedded Finance Market worth $228.79 billion by 2030, growing at a CAGR of 18.7 …
The "Embedded Finance Market by Services (Embedded Banking Services, Embedded Insurance, Embedded Lending), Integration Type (Application Programming Interfaces, Software Development Kits), Business Model, End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/embedded-finance Embedded Finance refers to the integration of financial services, such as lending, insurance, payments, or banking, directly within the products or services of non-financial companies using Application Programming Interfaces (APIs).
Currency Management Market worth $1,305.97 billion by 2030, growing at a CAGR of 15.74% - Exclusive Report by 360iResearch
Currency Management Market worth $1,305.97 billion by 2030, growing at a CAGR of …
The "Currency Management Market by Offering (Services, Software), Type (Fixed Currency Exchange, Floating Currency Exchange), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/currency-management Currency management encompasses strategies, methodologies, and tools employed by firms and financial institutions to address risks and potential benefits associated with currency fluctuations, involving activities such as hedging, arbitrage, and strategic investment planning to mitigate negative financial impacts
Bromacil Market worth $191.69 million by 2030, growing at a CAGR of 4.56% - Exclusive Report by 360iResearch
Bromacil Market worth $191.69 million by 2030, growing at a CAGR of 4.56% - Excl …
The "Bromacil Market by Formulation (Granular Formulation, Liquid Formulation), Distribution Channel (Offline, Online) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/bromacil Bromacil, a herbicide used to control broadleaf weeds and grasses, is vital for vegetation management in agricultural and non-cropland areas due to its soil-residual activity and efficacy in preventing weed growth, ultimately enhancing agricultural productivity and land utility. Applications span agricultural
Carbon Monoxide Market worth $7.92 billion by 2030, growing at a CAGR of 4.45% - Exclusive Report by 360iResearch
Carbon Monoxide Market worth $7.92 billion by 2030, growing at a CAGR of 4.45% - …
The "Carbon Monoxide Market by Purity Level (98% - 99%, Over 99%), Application (Chemical Synthesis, Food & Beverage, Fuel) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/carbon-monoxide The scope of carbon monoxide (CO) market research encompasses comprehensive evaluations of production, distribution, application, and end-use industries, providing insights into current market size, projected growth, and future demand across key regions such as North

All 5 Releases


More Releases for Assay

Creatinine Assay Kits Market
The global creatinine assay kits market is expected to reach USD 285.86 Million by 2025, from USD 192.07 Million in 2017 growing at a CAGR of 5.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-creatinine-assay-kits-market Some of the
Lateral Flow Assay Market
Worldwide Lateral Flow Assay Market Analysis to 2027 is a specialized and in-depth study of the Lateral Flow Assay industry with a focus on the global market trend. The report aims to provide an overview of global Lateral Flow Assay market with detailed market segmentation by product & services /application and geography. Get Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00005544/?utm_source=OpenPR&utm_medium=Sumaiya Lateral flow tests, also known as lateral flow immunochromatographic assays. The lateral flow assay
Transcreener® GDP GTPase Assay - The Only Mix-and-Read Fluorescent GTPase Assay …
The Transcreener GDP GTPase assay is a homogenous, fluorescent immunoassay that monitors the activity of GTPases along with GEF and GAP partners. The assay directly measures the amount of GDP produced in an in vitro GTPase reaction. BellBrook Labs' Transcreener GDP GTPase assays are available with fluorescence polarization (FP), fluorescence intensity (FI), and far-red, time-resolved Forster-resonance-energy-transfer (TR-FRET) readouts that provide a safe, HTS-compatible alternative to cumbersome radioassay methods and are more
High Throughput Flow Assay Trends 2017
ReportsWorldwide has announced the addition of a new report High Throughput Flow Assay Trends 2017 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on high throughput flow cytometry (HT flow) screening carried out in January 2017. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces and to update HTStec's previous HT
n Vitro Toxicology Market - By Method (Ex Vivo, Biochemical Assay, Cellular Assa …
Scientific analysis of the effects of toxic chemical substances on mammalian cells is called in vitro toxicology testing. It is employed in identification of hazardous chemicals and to confirm the lack of toxic properties in the early stages of the development new substances. In vitro toxicology testing is considered by key government agencies such as FDA and EPA in order to assess human risks. Rising opposition to animal testing, technological
ELISA Assay Dispensing Trends 2016
ReportsWorldwide has announced the addition of a new report ELISA Assay Dispensing Trends 2016 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on enzyme-linked immunosorbent assays (ELISA) carried out in April 2016. The survey was initiated by HTStec as part of its tracking of life science marketplaces and to update HTStec's previous ELISA Assay Trends report (June 2012).